CROI 2020 Abstract eBook

Abstract eBook

Keyword Index

SCD14 231 Screening 608, 621, 697, 746, 947, 1035, 1138 Self-testing 859, 879, 938, 955, 957, 958, 961, 962, 963, 964 Semen 594, 1055 Sequencing 66, 367, 376, 533, 973 SERINC5 21 Seroconversion 856, 949, 1003

Sustained virologic response 579, 581, 582, 583 Switch 36 Syndemic 558 Syndromic diagnosis 1040 Syphilis 1041, 1044, 1047, 1053 Systemic inflammation 589 Systems serology 287 -T- T cell 114, 201, 244, 424, 877 • activation 279, 814 • exhaustion 268 • profiling 304 • receptor repertoire 184, 361, 362

Transient elastography 544 Transinfection 171 Transmissible transfusion infections 145 Transmission 68, 510, 781, 787, 900, 907, 912, 924, 928, 1045 • clusters 510, 910, 922, 924, 929, 931 • dynamics 918, 936 • hotspots 925

Serodiscordance 1044 Set-point viral load 282 Sex differences 385 Sex workers 537, 854, 861, 905, 1013, 1016 Sex-specific analyses 862 Sexual • exposure 996 • health 984 • network 914, 1043, 1051 • partners 958, 1047 • risk behavior 1046, 1076 • transmission 598 • violence 1068

• network 908, 929 • networks 911, 915 • drug resistance 515 Transmitted founder virus 181, 186, 525 Transplantation 555, 577 Trauma 702, 897 Treatment 217, 379, 610, 886, 1099 • access 498 • as prevention 48, 498, 1076 • adherence 1102, 1105 • cascade 1072, 1080, 1095, 1097, 1127 • experienced 34, 507 • interruption 77, 319, 325, 326, 501 • Option 493 • Outcomes 136, 152, 740 • Therapy 482 TREG 369 Trehalose 207 Trends 244, 1100, 1123 Trimethoprim-sulfamethoxazole 137

• response 339, 384 • subpopulations 300 • trafficking 185, 273 T follicular helper 172 T follicular regulatory 172 T regulatory cells 588, 632 T1w/T2w 33 Talaromyces marneffei 749, 750, 751 Tanzania 537, 836

Sexually transmitted infections (STIs) 212, 984, 1035, 1040, 1042, 1043, 1044, 1046, 1047, 1048, 1049, 1053, 1055, 1056, 1133 Shedding 214, 1055 SHIV 76, 77, 78, 261, 286, 294, 345 Shock and kill 354 Signal-to-cutoff ratio 974 SIMOA 233 Simplification 486 Single • cell analysis 27, 127, 306, 360, 361 • cell RNA seq 637 • cell 258 • copy assay 310 • genome sequencing 366, 380, 383, 536, 813 • nucleotide polymorphism 670 Single-tablet regimen 840 SIV 68, 89, 117, 119, 197, 198, 201, 208, 219, 231, 252, 262, 278, 296, 320, 349, 423, 434 Skeletal muscle 705

Target enrichment 935 Target not detected 484 Targeted testing 944, 1087 Targeted therapy 353 TasP 1077, 1131 TBK-1 295 TDR 511 Telomere length 585, 651 Tenofovir alafenamide 81, 92, 445, 472, 509, 639, 655, 689, 715, 735, 764, 840, 990, 992, 997, 1020, 1028, 1032, 1089 Tenofovir detection 444, 497, 763 Tenofovir disoproxil fumarate 92, 501, 604, 655, 689, 692, 695, 822, 990, 1020, 1028, 1089 Tenofovir prodrug 610 Tenofovir-diphosphate 980 Test and treat 765, 1142 Test performance 951, 965, 967 Testing 141, 521, 779, 785, 859, 937, 940, 943, 946, 947, 948, 949, 953, 954, 956, 963, 964, 983, 1109, 1125, 1137 • coverage 963, 1125

TRN-SR2 22 Tropism 524

Truck drivers 962 Trunk fat 667, 827 TSNE 302 Tuberculin skin test 722, 728 Tuberculosis 138, 139, 717, 718, 719, 724, 725, 731, 732, 733, 734, 735, 738, 739, 741, 748, 757, 759, 761, 762 • And HIV 139, 471, 720, 723, 728, 730, 737, 738, 739, 740, 742, 758, 819, 846 • Diagnosis 723, 737, 756, 758, 759 • Meningitis 737 • Treatment 143, 724, 726, 729, 847 • Screening 723, 756 • Transmission 139, 718 Turnaround time 132 Two-drug regimen 483, 484, 486, 489, 493 Type I interferon 250 Type-I IFN 250, 254, 259 Tyrosine kinase inhibitors 64, 283 Tyrosine 703 -U- Uganda 496, 768, 959 UGT1A1 450 Ultradeep sequencing 425, 1002 Ultra-sensitive pharmacokinetic analyses 453 Uncoating 23, 182 Undetectable HIV viral load 739 Undetectable=Untrasmittable 444, 1082, 1130 Undiagnosed HIV 890 Universal test and treat 45, 1074, 1075, 1076, 1134, 1135 Unmet needs 888 Unprotected receptive rectal intercourse 594 Uptake 570 Urethra 211 Urine based assay 446 Urine tenofovir assay 91, 977 -V- V3 Region 294 Vaccination 114, 1026 Vaccine 78, 116, 287, 288, 289, 293, 294, 296, 297, 603 Vaccine response 292 VACS 684

Skin barrier integrity 212 Sleep quality 390, 644, 698 Social • determinants of health 872, 1085 • media 1013 • network 867, 890, 1136 • norms 496 Socioeconomic status 857, 874 Sociospatial Network 913 SOCS proteins 219 Sofosbuvir/velpatasvir 572 Soluble 638

• rates 815, 1096 • services 142, 815 • yield 815, 890, 949 Testosterone therapy 642 TET2 633 TFV-DP 445, 520, 1085 Th17 cells 174, 228, 249, 351, 588, 1062 Th22 cells 174 Thailand 852, 1010, 1013 Therapeutic drug monitoring 91 Therapeutic vaccine 266, 282 Thrombosis 639 Thymidine kinase 64

South Africa 69, 476, 519, 629, 718, 720, 755, 769, 773, 786, 798, 830, 834, 860, 864, 875, 899, 960, 969, 1015, 1070, 1074, 1075, 1081, 1121, 1134 Spatial analysis 913 Spleen 191 Spontaneous clearance 592 State sequence data analysis 926 Statins 447, 665, 706 STD clinic 986, 989 Steatosis 549 Stem cell transplantation 339 Stigma 1107 Stillbirth 1041 Stock-outs 1080 Streamlined care 1142 Strength 706 Stress 702 Stroke 28, 659, 664 Structure 25, 170, 180 Stunting 800 Sub-Saharan Africa 222, 533, 616, 659, 660, 681, 712, 777, 800, 848, 855, 856, 925, 958, 962, 1108, 1123, 1132, 1136 Substance use 553, 780, 833, 834, 891, 893, 898, 899, 1083 Subtypes 178, 933, 935 Succinate 402, 685

TIGIT+TIM3 302 TIM-3 266, 386 Tissue 371 Tissue compartments 316 Tissue resident 114 TLR 355 TLR-4 673 TLR7 agonist 77, 343 TLR7 320 Tocilizumab 113 Tolerability 436 Tomography 697 Topical 999 Total HIV-1 DNA 242 Toxicity 479, 734 Trabecular Bone Score 692 TRACE 755, 927

Keyword Index

Vaginal flora 459 Valproic acid 451 Vascular • Aging 641

Traditional risk factors 651 Transactional sex 855, 1132 Transcription 23, 314, 335, 360 Transcriptional profile 173 Transcriptome 835 Transcriptomics 184, 258, 304, 762 Transferrin 691 Transgender 253, 881, 884 • men 881, 979 • sex workers 879

Superinfection 193, 194 Suppressed switch 484

• Disease 653, 831 • Dysfunction 641 • Toxicity 639 Vertical transmission 134, 135, 184, 777 Vesatolimod 40, 345 Veterans 700 VH gene polymorphism 262 Vietnam 719, 1143 Vif 216

Suppression 35, 330 Suppressive ART 362 Surface engineering 357 Surveillance data 512, 590, 884, 901, 908 Surveillance 616, 909, 922, 926, 932, 1082, 1131 Survival Analysis 625, 863, 895, 1116 Survival 151, 479, 738, 868

• women 645, 852, 858, 878, 880, 882, 883, 914, 938, 979, 989, 1017, 1018, 1019, 1020, 1021, 1022, 1027, 1072, 1097 • women of color 949, 983

CROI 2020 467